Funding is key when it comes to developing an idea or research result. Every year, KTH Innovation helps KTH projects secure over 40 million SEK in funding.
View this resource Bookmark this resourcePrivate Funding Sources
Private venture capital, philanthropic foundations
The Fondation Maladies Rares is pleased to announce the launch of its “GenOmics” 2024 call for projects.
The aim of this AAP is to support hypothesis-driven research projects aimed at exploring the genetic and molecular basis of rare diseases using NGS approaches (WES, WGS, RNA-seq, small RNA-seq, ChIP-seq, Methyl-seq, etc.).
Support from the Fondation Maladies Rares will give project leaders access to innovative high-throughput sequencing technologies for the analysis of exomes, genomes, transcriptomes or epigenomes.
View this resource Bookmark this resource
Towards a Concrete Improvement in the Quality of Life of Patients with Autoimmune Myasthenia
Published by FONDATION MALADIES RARES
Autoimmune MyastheniaThe Fondation Maladies Rares and UCB have joined forces to offer a €30, 000 research grant to a humanities and social sciences (HSS) research project focused on findingconcrete, short-term ways ofimproving the life course of patients suffering from generalized autoimmune myasthenia gravis.
The grant will be awarded to a research project focusing on the individual, family and/or social consequences specifically linked to generalized autoimmune myasthenia gravis, in order to gain a better understanding of the impact of this disease, and in particular muscular fatigability, on quality of life at the level of the individual, couple or family, for example.
View this resource Bookmark this resource
Sanofi iAwards Europe
Published by SANOFI
ImmunologyInflammatory DiseasesRare and Neurological DiseasesCell and Gene TherapiesOncologyA booster to transform groundbreaking ideas in the field of target identification, disease knowledge and translational science into innovative therapeutic solutions. We partner with best-in-class academics to serve a common goal: accelerating innovation for patients.
View this resource Bookmark this resourceThis scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding that could improve human life, health and wellbeing.
View this resource Bookmark this resourceThe European Investment Bank and the European Commission have been working together for decades to develop innovative funding solutions. From traditional areas such as infrastructure, to emerging topics like research and innovation or projects to tackle climate change – our successful mandates and partnerships across Europe provide a solid foundation of finance opportunities. To discover more about some of these past initiatives, please see the list below.
View this resource Bookmark this resourceOIF will invest in early stage technology projects in order to make a return which is funnelled back into this self-sustaining “evergreen” fund. The OIF is endowed by charitable donors to the University as part of the Oxford Thinking campaign. It supports early-stage, proof-of-concept activity.
View this resource Bookmark this resource
LifeArc (MRC-Translation gap funding)
Published by OXFORD INVENTION FUND (OIF)
PrivateBasic ResearchPreclinical ResearchIndustrial Development or SMEClinical Reasearch
Italian Angels for Biotech
Published by ITALIAN ANGELS FOR BIOTECH
Venture Capital or Angel InvestmentPrivateBasic ResearchClinical ResearchPreclinical ResearchIndustrial Development or SME
Italian Angels for Growth
Published by ITALIAN ANGELS FOR GROWTH
Preclinical ResearchPrivateBasic ResearchClinical ResearchIndustrial Development or SMEVenture Capital or Angel Investment